Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06803290 · ClinicalTrials.gov registry record · Phase 1
Food Effect Study of VHX-896 in Healthy Volunteers
A Phase 1 study, sponsored by Vanda Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT06803290 is a Phase 1 study that has completed, run by Vanda Pharmaceuticals. The registered enrollment target is 24 participants.
The verdict
NCT06803290, a Phase 1 study, has completed, sponsored by Vanda Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
A single center, two-period, randomized study to evaluate the food effect of VHX-896 tablets in healthy volunteers
Interventions
- DRUG VHX-896
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2022-12-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06803290
The ClinicalTrials.gov registry entry for NCT06803290 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanda Pharmaceuticals, which has 68 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VHX-896 is the first listed.
NCT06803290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06803290 about?
NCT06803290 is a clinical study titled "Food Effect Study of VHX-896 in Healthy Volunteers". A single center, two-period, randomized study to evaluate the food effect of VHX-896 tablets in healthy volunteers
What is the current status of trial NCT06803290?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2022-06-21. Estimated completion is 2022-12-27.
What interventions are being tested in trial NCT06803290?
The interventions under investigation include: VHX-896 (DRUG).
Who is sponsoring clinical trial NCT06803290?
This trial is sponsored by Vanda Pharmaceuticals, which has 68 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.